drugset / Trial / NCT03431805

TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery

NCT03431805 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The aim is to assess the impact of tranexamic acid (TXA) for preventing postpartum hemorrhage (PPH) following a cesarean section (CS).

Timeline

Start
2018-03-03
Primary completion
2020-01-14
Completion
2020-04-08

Outcome

Met primary endpoint

paper The primary outcome occurred in 556 of 2086 women (26.7%) in the tranexamic acid group and in 653 of 2067 (31.6%) in the placebo group PMID 33913639 ↗

paper (adjusted risk ratio, 0.84; 95% confidence interval [CI], 0.75 to 0.94; P = 0.003). PMID 33913639 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.